{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T19:43:52Z","timestamp":1771875832938,"version":"3.50.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>An isopropanolic extract (iCR) from the rhizomes of Cimicifuga racemosa (black cohosh) is used an alternative in the treatment of menopausal symptoms, and animal studies suggest positive skeletal effects. iCR stimulated osteoblastic OPG protein secretion by 3- to 5-fold as early as 12 h without affecting RANKL expression. The iCR effect, abrogated by the pure estrogen receptor antagonist ICI 182,780, also enhanced ALP activity (4-fold) and osteocalcin expression (3-fold), possibly contributing to the skeletal effects of black cohosh.<\/jats:p>\n               <jats:p>Introduction: Despite its positive effects on the skeleton, estrogen replacement therapy is no longer recommended as first-line therapy for the prevention and treatment of postmenopausal osteoporosis because it increases cardiovascular, thromboembolic, and breast cancer risk. Recently, herbal therapeutics such as an isopropanolic extract (iCR) from the rhizomes of Cimicifuga (=Actaea) racemosa (black cohosh) are gaining interest as an alternative in the treatment of menopausal symptoms. Whereas animal studies in rats suggest positive skeletal effects, the mechanism of its actions on bone cells remain unclear. RANKL is essential for osteoclast formation and activation, while osteoprotegerin (OPG) neutralizes RANKL.<\/jats:p>\n               <jats:p>Materials and Methods: In this study, we assessed the effects of iCR on OPG and RANKL mRNA steady-state levels by semiquantitative RT-PCR and on protein production by an ELISA system in human osteoblasts (hOBs).<\/jats:p>\n               <jats:p>Results: Under serum-free conditions, treatment with iCR increased OPG mRNA levels and protein secretion of hOBs by 2- to 3-fold in a dose-dependent manner, with a maximum effect at a 106-fold dilution of iCR (p &amp;lt; 0.001) after 24\u201348 h. Time-course experiments indicated a stimulatory effect of iCR on osteoblastic OPG protein secretion by 3- to 5-fold (p &amp;lt; 0.001) as early as 12 h, whereas RANKL expression was very low and was not found to be modulated by iCR. Of note, the stimulatory effect of iCR on OPG production was abrogated by the pure estrogen receptor antagonist ICI 182,780. Moreover, iCR enhanced two osteoblastic differentiation markers, bone-specific alkaline phosphatase activity and osteocalcin expression, by up to 4- and 3-fold, respectively (p &amp;lt; 0.001).<\/jats:p>\n               <jats:p>Conclusions: Our data suggest that iCR enhances differentiation and increases the OPG-to-RANKL ratio of normal human osteoblasts. These effects may contribute to the positive skeletal effects of black cohosh.<\/jats:p>","DOI":"10.1359\/jbmr.050716","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T07:27:46Z","timestamp":1146122866000},"page":"2036-2043","source":"Crossref","is-referenced-by-count":30,"title":["Isopropanolic Extract of Black Cohosh Stimulates Osteoprotegerin Production by Human Osteoblasts"],"prefix":"10.1093","volume":"20","author":[{"given":"Volker","family":"Viereck","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Georg-August-University of G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Gr\u00fcndker","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Georg-August-University of G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie C","family":"Friess","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Georg-August-University of G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Heinz","family":"Frosch","sequence":"additional","affiliation":[{"name":"Department of Trauma Surgery, Georg-August-University of G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Raddatz","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Endocrinology, Georg-August-University of G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schoppet","sequence":"additional","affiliation":[{"name":"Department of Medicine, Philipps-University of Marburg, Marburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Nisslein","sequence":"additional","affiliation":[{"name":"Schaper & Br\u00fcmmer Co., R & D-Department of Veterinary Medicine, Saltzgitter, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnter","family":"Emons","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Georg-August-University of G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenz C","family":"Hofbauer","sequence":"additional","affiliation":[{"name":"Department of Medicine, Philipps-University of Marburg, Marburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,12,4]]},"reference":[{"key":"2024013019260817700_bib1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.4065\/74.6.601","article-title":"Selective estrogen receptor modulators and phytoestrogens: New therapies for the postmenopausal women","volume":"74","author":"Fitzpatrick","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"2024013019260817700_bib2","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1503\/cmaj.1030757","article-title":"Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: Recommendation statement from the Canadian Task Force on Preventive Health Care","volume":"170","author":"Cheung","year":"2004","journal-title":"Can Med Assoc J"},{"key":"2024013019260817700_bib3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.tem.2005.05.002","article-title":"Black cohosh\u2014just another phytoestrogen","volume":"16","author":"Viereck","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"2024013019260817700_bib4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00774-003-0431-9","article-title":"Effects of an isopropanolic extract of Cimicifuga racemosa on urinary crosslinks and other parameters of bone quality in an ovariectomized rat model of osteoporosis","volume":"21","author":"Nisslein","year":"2003","journal-title":"J Bone Miner Metab"},{"key":"2024013019260817700_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.maturitas.2004.07.007","article-title":"Effects of estradiol-17\u03b2, testosterone and a black cohosh preparation on bone and prostate in orchidectomized rats","volume":"51","author":"Seidlov\u00e1-Wuttke","year":"2005","journal-title":"Maturitas"},{"issue":"Suppl 1","key":"2024013019260817700_bib6","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0378-5122(02)00347-X","article-title":"Pharmacology of Cimicifuga racemosa extract BNO 1055 in rats: Bone, fat and uterus","volume":"44","author":"Seidlov\u00e1-Wuttke","year":"2003","journal-title":"Maturitas"},{"issue":"Suppl 1","key":"2024013019260817700_bib7","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S0378-5122(02)00350-X","article-title":"The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: Effects on menopause symptoms and bone markers","volume":"44","author":"Wuttke","year":"2003","journal-title":"Maturitas"},{"key":"2024013019260817700_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/07853899309147298","article-title":"Oestrogen effects on osteoblasts and osteoclasts","volume":"25","author":"Oursler","year":"1993","journal-title":"Ann Med"},{"key":"2024013019260817700_bib9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1359\/jbmr.2001.16.2.214","article-title":"Localization of estrogen receptor \u03b2 protein expression in adult human bone","volume":"16","author":"Braidman","year":"2001","journal-title":"J Bone Miner Res"},{"key":"2024013019260817700_bib10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1210\/mend.13.6.0299","article-title":"The actions and interactions of sex steroids and growth factors\/cytokines on the skeleton","volume":"13","author":"Spelsberg","year":"1999","journal-title":"Mol Endocrinol"},{"key":"2024013019260817700_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: A novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"2024013019260817700_bib12","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/endo.139.3.5837","article-title":"Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG\/OCIF inhibits osteoclastogenesis in vitro","volume":"139","author":"Yasuda","year":"1998","journal-title":"Endocrinology"},{"key":"2024013019260817700_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin (OPG) ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"2024013019260817700_bib14","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","article-title":"Bone resorption by osteoclasts","volume":"289","author":"Teitelbaum","year":"2000","journal-title":"Science"},{"key":"2024013019260817700_bib15","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1210\/endo.140.9.7131","article-title":"Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"2024013019260817700_bib16","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/jcb.10087","article-title":"Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts","volume":"84","author":"Viereck","year":"2002","journal-title":"J Cell Biochem"},{"key":"2024013019260817700_bib17","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1210\/jc.2002-021877","article-title":"Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts","volume":"88","author":"Viereck","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019260817700_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/(SICI)1097-4644(19991001)75:1<22::AID-JCB3>3.0.CO;2-6","article-title":"Developmental of the osteoblast phenotype in primary human osteoblasts in culture: Comparison with rat calvarial cells in osteoblast differentiation","volume":"75","author":"Siggelkow","year":"1999","journal-title":"J Cell Biochem"},{"key":"2024013019260817700_bib19","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/endo.140.10.7034","article-title":"Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: Potential paracrine mechanisms of glucocorticoid-induced osteoporosis","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"2024013019260817700_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1365-2036.2003.01802.x","article-title":"Glucocorticoid receptor expression in inflammatory bowel disease: Evidence for a mucosal down-regulation in steroid-unresponsive ulcerative colitis","volume":"19","author":"Raddatz","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"2024013019260817700_bib21","doi-asserted-by":"crossref","first-page":"11879","DOI":"10.1016\/S0021-9258(18)80148-X","article-title":"Localization of 1,25-(OH)2D3-responsive alkaline phosphatase in osteoblast-like cells (ROS 17\/2.8, MG 63, and MC3T3) and growth cartilage cells in culture","volume":"264","author":"Boyan","year":"1989","journal-title":"J Biol Chem"},{"key":"2024013019260817700_bib22","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1006\/bbrc.2002.6510","article-title":"Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts","volume":"291","author":"Viereck","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"2024013019260817700_bib23","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1210\/endo.142.8.8346","article-title":"Leptin reduces ovariectomy-induced bone loss in rats","volume":"142","author":"Burguera","year":"2001","journal-title":"Endocrinology"},{"key":"2024013019260817700_bib24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1210\/edrv.23.1.0456","article-title":"Changes in proinflammatory cytokine activity after menopause","volume":"23","author":"Pfeilschifter","year":"2002","journal-title":"Endocr Rev"},{"key":"2024013019260817700_bib25","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1056\/NEJM199310143291601","article-title":"The effect of postmenopausal estrogen therapy on bone density in elderly women","volume":"329","author":"Felson","year":"1993","journal-title":"N Engl J Med"},{"key":"2024013019260817700_bib26","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0950-351X(98)80003-7","article-title":"Phytoestrogens and bone","volume":"12","author":"Anderson","year":"1998","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"2024013019260817700_bib27","first-page":"188","volume-title":"World Cancer Report","author":"World","year":"2003"},{"key":"2024013019260817700_bib28","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-2007-969500","article-title":"The endocrine effects of constituents of Cimicifuga racemosa. 2. In vitro binding of constituents to estrogen receptors","volume":"51","author":"Jarry","year":"1985","journal-title":"Planta Med"},{"key":"2024013019260817700_bib29","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0378-5122(02)00346-8","article-title":"In vitro effects of the Cimicifuga racemosa extract BNO 1055","volume":"44","author":"Jarry","year":"2003","journal-title":"Maturitas"},{"key":"2024013019260817700_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/B:BREA.0000018413.98636.80","article-title":"Cimicifuga racemosa extract inhibits proliferation of estrogen receptor-positive and negative human breast carcinoma cell lines by induction of apoptosis","volume":"84","author":"Hostanska","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"2024013019260817700_bib31","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1248\/bpb.27.1970","article-title":"Evaluation of cell death caused by triterpene glycosides and phenolic substances from Cimicifuga racemosa extract in human MCF-7 breast cancer cells","volume":"27","author":"Hostanska","year":"2004","journal-title":"Biol Pharm Bull"},{"key":"2024013019260817700_bib32","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1081\/CNV-200026394","article-title":"Pilot evaluation of black cohosh for the treatment of hot flashes in women","volume":"22","author":"Pockaj","year":"2004","journal-title":"Cancer Invest"},{"key":"2024013019260817700_bib33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S8756-3282(02)00953-5","article-title":"The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts","volume":"32","author":"Ireland","year":"2003","journal-title":"Bone"},{"key":"2024013019260817700_bib34","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1021\/jf034264r","article-title":"Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor","volume":"51","author":"Burdette","year":"2003","journal-title":"J Agricult Food Chem"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2FJBMR.050716","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/20\/11\/2036\/56475554\/5650201117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/20\/11\/2036\/56475554\/5650201117.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:09:58Z","timestamp":1710342598000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/20\/11\/2036-2043\/7592879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,1]]},"references-count":34,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2009,12,4]]},"published-print":{"date-parts":[[2005,11,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.050716","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2005,11,1]]},"published":{"date-parts":[[2005,11,1]]}}}